Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 Jul;109(3):788–792. doi: 10.1111/j.1476-5381.1993.tb13643.x

Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption.

H Kaube 1, K L Hoskin 1, P J Goadsby 1
PMCID: PMC2175651  PMID: 8395298

Abstract

1. The 5-hydroxytryptamine (5-HT1)-like agonist, sumatriptan, is highly efficient in the relief of migraine headache and its accompanying symptoms. 2. Experimental evidence has indicated that its site of action may be on the cranial vessels or on the trigeminal innervation of the cranium, or both, since sumatriptan does not pass the blood-brain barrier easily under normal circumstances. It is, however, not clear whether the blood-brain barrier is normal or abnormal during a migraine attack. 3. In this study, single unit activity and trigeminal somatosensory evoked potentials in central trigeminal neurones were monitored during electrical stimulation of the superior sagittal sinus. 4. Intravenous administration of sumatriptan (100 micrograms kg-1) did not alter trigeminal evoked activity unless the permeability of the blood-brain barrier had been increased by infusion of an hyperosmolar mannitol solution. After blood-brain barrier disruption, sumatriptan decreased the peak-to-peak amplitude of evoked potentials by 40 +/- 6% and the probability of firing of single units by 30 +/- 9%. Mannitol infusions alone in control animals caused no changes in evoked potentials or single unit activity. 5. The data suggest that in normal circumstances sumatriptan does not have sufficient access to trigeminal neurons to alter their function.

Full text

PDF
788

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Connor H. E., Stubbs C. M., Feniuk W., Humphrey P. P. Effect of sumatriptan, a selective 5-HT1-like receptor agonist, on pial vessel diameter in anaesthetised cats. J Cereb Blood Flow Metab. 1992 May;12(3):514–519. doi: 10.1038/jcbfm.1992.70. [DOI] [PubMed] [Google Scholar]
  2. Cosolo W. C., Martinello P., Louis W. J., Christophidis N. Blood-brain barrier disruption using mannitol: time course and electron microscopy studies. Am J Physiol. 1989 Feb;256(2 Pt 2):R443–R447. doi: 10.1152/ajpregu.1989.256.2.R443. [DOI] [PubMed] [Google Scholar]
  3. Feniuk W., Humphrey P. P., Perren M. J., Connor H. E., Whalley E. T. Rationale for the use of 5-HT1-like agonists in the treatment of migraine. J Neurol. 1991;238 (Suppl 1):S57–S61. doi: 10.1007/BF01642908. [DOI] [PubMed] [Google Scholar]
  4. Goadsby P. J., Gundlach A. L. Localization of 3H-dihydroergotamine-binding sites in the cat central nervous system: relevance to migraine. Ann Neurol. 1991 Jan;29(1):91–94. doi: 10.1002/ana.410290116. [DOI] [PubMed] [Google Scholar]
  5. Goadsby P. J., Zagami A. S., Donnan G. A., Symington G., Anthony M., Bladin P. F., Lance J. W. Oral sumatriptan in acute migraine. Lancet. 1991 Sep 28;338(8770):782–783. doi: 10.1016/0140-6736(91)90666-d. [DOI] [PubMed] [Google Scholar]
  6. Goadsby P. J., Zagami A. S., Lambert G. A. Neural processing of craniovascular pain: a synthesis of the central structures involved in migraine. Headache. 1991 Jun;31(6):365–371. doi: 10.1111/j.1526-4610.1991.hed3106365.x. [DOI] [PubMed] [Google Scholar]
  7. Goadsby P. J., Zagami A. S. Stimulation of the superior sagittal sinus increases metabolic activity and blood flow in certain regions of the brainstem and upper cervical spinal cord of the cat. Brain. 1991 Apr;114(Pt 2):1001–1011. doi: 10.1093/brain/114.2.1001. [DOI] [PubMed] [Google Scholar]
  8. Humphrey P. P., Feniuk W., Marriott A. S., Tanner R. J., Jackson M. R., Tucker M. L. Preclinical studies on the anti-migraine drug, sumatriptan. Eur Neurol. 1991;31(5):282–290. doi: 10.1159/000116755. [DOI] [PubMed] [Google Scholar]
  9. Humphrey P. P., Feniuk W., Perren M. J., Beresford I. J., Skingle M., Whalley E. T. Serotonin and migraine. Ann N Y Acad Sci. 1990;600:587–600. doi: 10.1111/j.1749-6632.1990.tb16912.x. [DOI] [PubMed] [Google Scholar]
  10. Kaube H., Hoskin K. L., Goadsby P. J. Activation of the trigeminovascular system by mechanical distension of the superior sagittal sinus in the cat. Cephalalgia. 1992 Jun;12(3):133–136. doi: 10.1046/j.1468-2982.1992.1203133.x. [DOI] [PubMed] [Google Scholar]
  11. Lambert G. A., Goadsby P. J., Zagami A. S., Duckworth J. W. Comparative effects of stimulation of the trigeminal ganglion and the superior sagittal sinus on cerebral blood flow and evoked potentials in the cat. Brain Res. 1988 Jun 21;453(1-2):143–149. doi: 10.1016/0006-8993(88)90152-7. [DOI] [PubMed] [Google Scholar]
  12. Markowitz S., Saito K., Moskowitz M. A. Neurogenically mediated plasma extravasation in dura mater: effect of ergot alkaloids. A possible mechanism of action in vascular headache. Cephalalgia. 1988 Jun;8(2):83–91. doi: 10.1046/j.1468-2982.1988.0802083.x. [DOI] [PubMed] [Google Scholar]
  13. Moskowitz M. A., Buzzi M. G. Neuroeffector functions of sensory fibres: implications for headache mechanisms and drug actions. J Neurol. 1991;238 (Suppl 1):S18–S22. doi: 10.1007/BF01642901. [DOI] [PubMed] [Google Scholar]
  14. Sleight A. J., Cervenka A., Peroutka S. J. In vivo effects of sumatriptan (GR 43175) on extracellular levels of 5-HT in the guinea pig. Neuropharmacology. 1990 Jun;29(6):511–513. doi: 10.1016/0028-3908(90)90061-u. [DOI] [PubMed] [Google Scholar]
  15. Treatment of migraine attacks with sumatriptan. The Subcutaneous Sumatriptan International Study Group. N Engl J Med. 1991 Aug 1;325(5):316–321. doi: 10.1056/NEJM199108013250504. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES